Saturday, December 04, 2004

GAO Report Eases Biotech Fears...

for investors. Because that's what it's really about.
href="http://www.forbes.com/home_europe/sciencesandmedicine/2004/12/02/
cx_mh_1202gao.html" target=_blank>Biotech investors have been nervous
about new rules regarding how doctors are compensated for the cost of
giving chemotherapy drugs to Medicare and Medicaid patients. But a new
report from the federal Government Accountability Office (GAO) may have
given investors new confidence and fueled today's sector-wide stock
rally.


posted by ryan griffis  # 12:31 AM

Comments: Post a Comment



Links to this post:

Create a Link



<< Home

Archives

June 2004   July 2004   August 2004   September 2004   October 2004   November 2004   December 2004   January 2005   February 2005   March 2005   April 2005   May 2005   June 2005   July 2005   August 2005   September 2005   October 2005   November 2005   December 2005   January 2006   February 2006   March 2006   April 2006   May 2006   June 2006   July 2006   August 2006   September 2006   October 2006   November 2006   December 2006   January 2007   February 2007   March 2007   April 2007   May 2007   June 2007   July 2007  

syndicate [atom]

preBlog archives

This page is powered by Blogger. Isn't yours?